Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$9,629,129
-$2,311,535 QoQ
Shares Held
76,216
-11.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#437
of 2,265 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $241,408,936 across 16 Drug Manufacturers - General names. GILD ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
234,831 | $59,640,029 | |
| 2 | LLY |
ELI LILLY & Co
|
34,121 | $40,925,754 | |
| 3 | ABBV |
AbbVie Inc.
|
154,317 | $38,832,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
190,293 | $24,452,650 | |
| 5 | AMGN |
Amgen Inc
|
43,724 | $15,833,334 | |
| 6 | AZN |
Astrazeneca PLC
|
69,989 | $13,271,314 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
76,216 | $9,629,129 | |
| 8 | NVS |
Novartis AG
|
60,245 | $9,441,596 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,629,129 | 76,216 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $11,940,664 | 85,676 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,796,578 | 87,963 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $8,331,327 | 75,057 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $8,761,612 | 79,026 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $7,242,239 | 64,634 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,224,167 | 67,383 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,928,956 | 82,645 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,934,696 | 86,499 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,556,973 | 89,515 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $6,238,418 | 77,008 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,457,580 | 72,826 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $5,650,078 | 73,311 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,683,897 | 80,558 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $9,765,265 | 113,748 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $7,483,613 | 121,310 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $6,952,512 | 112,482 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,402,816 | 90,880 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $5,459,255 | 75,186 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $5,196,071 | 74,389 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,031,875 | 73,074 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,533,729 | 70,149 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,656,921 | 62,769 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,952,236 | 46,720 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $7,106,870 | 92,369 | Shares | Sole | 2020-09-22 | |
| No filing history on record for this holder in this stock. | ||||||